PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
144.54%
Net income growth above 1.5x EQT's 59.01%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
6.81%
D&A growth of 6.81% while EQT is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
132.49%
Some yoy growth while EQT is negative at -64.17%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-583.57%
Negative yoy working capital usage while EQT is 178.21%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-101.49%
Both negative yoy, with EQT at -97.89%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-155.54%
Negative yoy CFO while EQT is 59.05%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-25.36%
Negative yoy CapEx while EQT is 33.65%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-1.35%
Negative yoy acquisition while EQT stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-137.59%
We reduce yoy other investing while EQT is 106.14%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-148.60%
We reduce yoy invests while EQT stands at 35.81%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
4.34%
We repay more while EQT is negative at -85.19%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
300.00%
Issuance growth of 300.00% while EQT is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.